Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and pharmacokinetic data support once-daily low-dose boosted saquinavir (1,200 milligrams saquinavir with 100 milligrams ritonavir) in treatment-naive or limited protease inhibitor-experienced human immunodeficiency virus-infected patients.
Marin-Niebla A, Lopez-Cortes LF, Ruiz-Valderas R, Viciana P, Mata R, Gutierrez A, Pascual R, Rodriguez M. Marin-Niebla A, et al. Antimicrob Agents Chemother. 2007 Jun;51(6):2035-42. doi: 10.1128/AAC.01136-06. Epub 2007 Mar 19. Antimicrob Agents Chemother. 2007. PMID: 17371813 Free PMC article. Clinical Trial.
Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen.
Lopez-Cortes LF, Ruiz-Valderas R, Ruiz-Morales J, Leon E, de Campos AV, Marin-Niebla A, Marquez-Solero M, Lozano F, Valiente R. Lopez-Cortes LF, et al. Among authors: marin niebla a. J Antimicrob Chemother. 2006 Nov;58(5):1017-23. doi: 10.1093/jac/dkl357. Epub 2006 Sep 6. J Antimicrob Chemother. 2006. PMID: 16956905 Clinical Trial.
Transfusion of erythrocyte concentrates produces a variable increment on cerebral oxygenation in patients with severe traumatic brain injury: a preliminary study.
Leal-Noval SR, Rincón-Ferrari MD, Marin-Niebla A, Cayuela A, Arellano-Orden V, Marín-Caballos A, Amaya-Villar R, Ferrándiz-Millón C, Murillo-Cabeza F. Leal-Noval SR, et al. Among authors: marin niebla a, marin caballos a. Intensive Care Med. 2006 Nov;32(11):1733-40. doi: 10.1007/s00134-006-0376-2. Epub 2006 Sep 22. Intensive Care Med. 2006. PMID: 17019549
Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphoma.
De la Cruz Vicente F, Carrillo-Cruz E, Rodriguez MS, Marín Niebla A, Galiana ML, Gonzalez JF, Cuadrado IM, Campos JG, Tocino IE, Rios-Herranz E, Perez-Simón JA. De la Cruz Vicente F, et al. Among authors: marin niebla a. Eur J Haematol. 2014 Dec;93(6):469-75. doi: 10.1111/ejh.12384. Epub 2014 Jul 2. Eur J Haematol. 2014. PMID: 24853381
35 results